Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide.

    Martínez-López J, Rivero A, Rapado I, Montalbán C, Paz-Carreira J, Canales M, Martínez R, Sánchez-Godoy P, Fernández de Sevilla A, Peñalver FJ, Gonzalez M, Prieto E, Salar A, Burgaleta C, Queizán JA, Peñarrubia MJ, Monteagudo MD, Cabrera C, De la Serna J, Tomás JF.

    Leuk Lymphoma. 2009 Aug;50(8):1283-9.PMID: 19557622 [PubMed - in process]Related articles

    2.

    Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

    Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-Vence N, González-Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A; Spanish Group for the Study of CNS Disease in NHL.

    J Clin Oncol. 2009 Mar 20;27(9):1462-9. Epub 2009 Feb 17.PMID: 19224854 [PubMed - indexed for MEDLINE]Related articles

    3.

    Rituximab for patients with idiopathic thrombocytopenic purpura.

    Peñalver FJ, Cabrera JR.

    Ann Intern Med. 2007 Aug 21;147(4):281; author reply 281-2. No abstract available. PMID: 17709765 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.

    Peñalver FJ, Jiménez-Yuste V, Almagro M, Alvarez-Larrán A, Rodríguez L, Casado M, Gallur L, Giraldo P, Hernández R, Menor D, Rodríguez MJ, Caballero D, González R, Mayans J, Millán I, Cabrera JR; Multi-institutional Retrospective Spanish Study Group on the Use of Rituximab in Refractory ITP.

    Ann Hematol. 2006 Jun;85(6):400-6. Epub 2006 Mar 21. Erratum in: Ann Hematol. 2006 Aug;85(8):558. Dosage error in article text. PMID: 16550390 [PubMed - indexed for MEDLINE]Related articles

    5.

    Infusion of lymphocytes obtained from a donor immunised with the paraprotein idiotype as a treatment in a relapsed myeloma.

    Cabrera R, Díaz-Espada F, Barrios Y, Briz M, Forés R, Barbolla L, Sanjuán I, Regidor C, Peñalver FJ, Fernández MN.

    Bone Marrow Transplant. 2000 May;25(10):1105-8.PMID: 10828874 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Ischemic stroke as first manifestation of chronic myelogenous leukemia]

    Benito-León J, Sánchez J, Osorio S, Peñalver FJ.

    Rev Neurol. 1999 Aug 16-31;29(4):391-2. Spanish. No abstract available. PMID: 10797937 [PubMed - indexed for MEDLINE]Related articles

    7.

    Mucormycosis and hemopoietic transplants.

    Peñalver FJ, Romero R, Forés R, Cabrera R, Briz M, Fernández M.

    Haematologica. 1998 Oct;83(10):950-1.PMID: 9830806 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Rhinocerebral mucormycosis following donor leukocyte infusion: successful treatment with liposomal amphotericin B and surgical debridement.

    Peñalver FJ, Romero R, Forés R, Cabrera R, Díez-Martin JL, Regidor C, Fernández MN.

    Bone Marrow Transplant. 1998 Oct;22(8):817-8.PMID: 9827982 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [The influence of a prior appointment on primary care consultations in the Murcia region]

    Moreno E, Gómez-Calcerada D, Sandoval C, Cánovas J, Ramos C, Peñalver FJ, Guillén F, Marset P.

    Aten Primaria. 1992 Jan;9(1):20-3. Spanish. PMID: 1308444 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...